We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRB icon
2801
H&R Block
HRB
$5.61B
– –
-40,456
Closed -$882K
HRMY icon
2802
Harmony Biosciences
HRMY
$2.08B
– –
-15,545
Closed -$514K
HROW icon
2803
Harrow
HROW
$1.45B
– –
-29,272
Closed -$198K
HSTM icon
2804
HealthStream
HSTM
$824M
– –
-13,218
Closed -$295K
HSY icon
2805
Hershey
HSY
$35.9B
– –
-3,734
Closed -$590K
HTOO icon
2806
Fusion Fuel Green
HTOO
$8.57M
– –
-974
Closed -$457K
HUBS icon
2807
HubSpot
HUBS
$11.9B
– –
-20,348
Closed -$9.24M
HUMA icon
2808
Humacyte
HUMA
$181M
– –
-45,590
Closed -$494K
HUN icon
2809
Huntsman Corp
HUN
$2.12B
– –
-181,808
Closed -$5.24M
HUYA
2810
Huya Inc
HUYA
$570M
– –
-88,184
Closed -$1.72M
HXL icon
2811
Hexcel
HXL
$7.76B
– –
-5,186
Closed -$290K
HYFM icon
2812
Hydrofarm Holdings
HYFM
$2.82M
– –
-928
Closed -$560K
IBM icon
2813
PUT
IBM
IBM
$209B
– –
-13,598
Closed -$1.73M
ICE icon
2814
Intercontinental Exchange
ICE
$88.4B
– –
-5,246
Closed -$586K
ICUI icon
2815
ICU Medical
ICUI
$4.21B
– –
-2,887
Closed -$593K
IDYA icon
2816
IDEAYA Biosciences
IDYA
$3.5B
– –
-10,160
Closed -$239K
IGMS
2817
DELISTED
IGM Biosciences
IGMS
– –
-26,046
Closed -$2M
NBP
2818
NovaBridge Biosciences American Depositary Shares
NBP
$190M
– –
-53,596
Closed -$2.6M
IMMR icon
2819
Immersion
IMMR
$246M
– –
-33,591
Closed -$322K
IMNN icon
2820
Imunon
IMNN
$6.72M
– –
-662
Closed -$179K
INO icon
2821
Inovio Pharmaceuticals
INO
$54M
– –
-65,401
Closed -$7.28M
INTC icon
2822
CALL
Intel
INTC
$460B
– –
-3,300
Closed -$211K
IPWR icon
2823
Ideal Power
IPWR
$60.9M
– –
-58,187
Closed -$770K
IRM icon
2824
Iron Mountain
IRM
$37.1B
– –
-5,716
Closed -$212K
IRTC icon
2825
iRhythm Holdings
IRTC
$3.91B
– –
-30,306
Closed -$4.21M
111 112
113
114 115

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.